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Abstract
Background: Tuberculosis is one of  the world’s most common causes of  death in the era of  Human immunodeficiency virus. 
The purpose of  this study was to determine the prevalence and associated factors of  TB/HIV co-infection.
Methods: Hospital based retrospective studies were conducted among adult HIV-positive patients. Logistic regression method 
and Chi square test were applied.
Results: A total of  571 HIV positive study participants were enrolled. Of  these, 158 (27.7%) were found to have pulmonary 
tuberculosis. Lower baseline CD4 count<200cell/μl, patients who drunk alcohol, patients who were ambulatory at the initiation 
of  ART, patients whose marital status was single were significant predictors for increased risk of  tuberculosis in PLWHIV (P 
<0.05). Non smoker patients, patients in WHO clinical stage I, patients in WHO clinical stage II and ownership of  the house 
had significant protective benefit against risk of  TB (P <0.05).
Conclusion: The prevalence of  TB/HIV co-infection in adults on ART in our study was moderately high. Having advanced 
clinical status and presence of  risk factors were found to be the predicting factors for co-infection. The health office should 
open TB/HIV co-infection units in the hospitals and health workers should be cautious when a patient has an advanced disease.
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Background
Tuberculosis (TB) is one of  the world’s most common 
causes of  death in the era of  Human Immunodeficiency 
Virus (HIV). It is among the leading causes of  death for 
people living with HIV (PLWHIV) which shares about 
twenty-five percent of  all causes of  the deaths1. HIV 
promotes progression of  latent or recent infections of  
Mycobacterium tuberculosis to active disease and also 
increases the rate of  occurrence of  TB2. PLWHIV may 
also be more susceptible to TB infection3. HIV is the first 
and TB is the second leading cause of  death from infec-
tious disease worldwide4. Globally, there were an estimat-
ed 9 million incident cases of  TB in 2013 with 13% co-
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infected with HIV. There were an estimated 1.5 million 
TB deaths (1.1 million among HIV-negative people and 
0.4 million among HIV-positive people)5. Hospital data 
indicated that TB is the leading cause of  morbidity and 
the third cause of  hospital admissions in the country6. 
According to World Health Organization report Ethiopia 
ranks 7th among the 22 high burden countries with TB 
and HIV infection in the world7.
TB/HIV co-infection is associated with special diag-
nostic and therapeutic challenges and constitutes an im-
mense burden on healthcare systems of  heavily infected 
countries like Ethiopia8. Studies indicated that certain 
HIV-infected people develop TB, while others do not. 
This phenomenon iterates that being HIV positive is not 
the only factor for being infected with TB, and there are 
various determinant factors that contribute to the TB/
HIV co-infection9-11. Understanding the predictors of  
TB/HIV co-infections in the local context is critical for 
Ethiopia to improve TB/HIV co-infected patients’ co-
management. Therefore, the main goal of  this study was 
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to determine prevalence and associated factors of  TB 
co-infection among HIV patients in the HIV clinics in 
Amhara Region, Ethiopia. It is anticipated that findings 
from this study will contribute to the body of  knowledge 
that informs TB/HIV program planners, decision mak-
ers, and project implementers by providing predictors of  
TB/HIV co-infection.
Methods
Study design and area
Hospital based retrospective studies were conducted 
among adult HIV-positive patients attending HIV clinic 
between June 2006 and January 2014 in Amhara Region, 
Ethiopia. The Amhara Region is located in the North-
Western and North Central parts of  Ethiopia and lies 
within 90 and 23045’N and 360 and 40030’E. Elevation 
ranges from 700m in the Eastern parts to over 4620m in 
the NorthWest. It has a total area of  170,000km2, which 
is divided in to 11 administrative Zones and 105 Weredas. 
In this region, there are 5 referral hospitals. The sources 
of  data for this study were Felege Hiwot, Gonder Univer-
sity, Dessie, Debere Berihan and Debere Markos referral 
Hospitals. The sampling frame consisted of  65000 HIV/
AIDS patients who have visited these referral hospitals 
since the initiation of  ART.
Sample size and sampling procedure 
Sample size was calculated using single population pro-
portion formula using 95% confidence level, 4% degree 
of  precision and 33% proportion ofTB/HIV co-infec-
tion17. The sample size was 520 which after adding 10% 
for non-response gave an overall sample size of  572. A 
stratified random sampling method was adopted for se-
lecting a representative sample. The sample size was al-
located proportionally based on the number of  patients 
in each referral hospital. Patients were selected randomly 
using their ART unique identification number. The study 
considered all HIV infected patients on ART, whose age 
was >15 years regardless of  their treatment category dur-
ing the study period in the referral hospitals.
Measurements
The response variable for this study was the occurrence 
of  TB/HIV co-infection. The predictor variables includ-
ed socio-demographic and economic characteristics (age, 
sex, income, employment status, residence, educational 
status, and marital status) and clinical related characteris-
tics (WHO clinical stage, baseline CD4 count, month on 
ART, functional status, and smoking status).
Functional status was measured at baseline, and a per-
son was categorized as working if  “he/she was able to 
perform usual work in or out of  the house”; ambulatory 
if  “he/she was able to perform activities of  daily living” 
and bedridden if  “he/she was not able to perform activi-
ties of  daily living”. Alcohol use was categorized as “yes” 
if  a person was currently or previously an alcoholic bev-
erages consumer and “no” if  he/she had never been an 
alcoholic beverages consumer.
Data collection
Nurses who worked in ART clinics were selected to col-
lect data from January, 2013 to January, 2014. A struc-
tured questionnaire was used to collect data on socio 
demographic, behavioral and economic factors. All re-
cords of  HIV/AIDS patients between June 2006 and 
September 2014 were considered for data collection. Lab 
requests, follow-up forms, anti-TB record forms, ART 
intake forms, and patient cards were reviewed. Labora-
tory results recorded before starting ART were used as 
base line values. If  there was no pre-treatment laboratory 
test, however, results obtained within one month of  ART 
initiation were considered as baseline values. Data quality 
was assured by using a pre-tested data collection tool and 
trained data collectors. Two professionals were engaged 
in continuous supervision and monitoring. Completeness 
and consistency of  data was checked by supervisors, data 
clerks and investigators before and after data entry.
Ethics statement
This investigation was conducted according to the princi-
ples expressed in the Declaration of  Bahir Dar Universi-
ty, Ethiopia. It was approved by the research ethics com-
mittee at Bahir Dar University and all participants who 
agreed to participate in this study signed a consent form.
Data analysis
The data was coded and entered to Epi Info 3.14 for Win-
dows. Statistical package for social science (SPSS) version 
20 and STATA version 12.0 were used for analysis. De-
scriptive statistics were used to assess normality, outliers 
and identify missing values. Chi square test and indepen-
dent t-test were used to test the relationship between each 
covariate and TB/HIV co-infection status. Multi covari-
ate logistic regression was done by entering all variables 
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with P value less than 0.25 in the bivariate analysis. Fi-
nally, logistic regression with forward likelihood selection 
method with P value less than 0.05 was used to identify 
the determinant factors associated with TB/HIV co-in-
fection. The crude and adjusted odds ratio (OR) and its 
95% confidence interval (CI) were estimated. 
Results
Descriptive statistics for socio-demographic and 
economic factors
There were 571 respondents in the study. Of  these, 413 
(72.3%) were not found to have TB/HIV-co infection 
while 158(27.7%) had TB/HIV co-infection. The pro-
portion of  female respondents who had TB/HIV-co in-
fection accounted for a larger proportion in the sample 
107(69%) compared to male respondents 48(31%). Pa-
tients with primary education accounted for the larger 
proportion 64(40%) of  having TB/HIV co-infection 
compared to those with no education 39(24.8%), sec-
ondary education 33(21%), and certificate and above 
21(13.4%). 
In addition, majority of  TB/HIV patients 130(82.8%) 
were urban residents while 27(17.2%) were residing 
in rural areas. Among TB/HIV co-infected patients, 
149(96.8%) were non smokers 123(79.9%) of  TB/HIV 
co-infected patients were nonalcoholics. The majority of  
participants who had TB/HIV co-infection, 104(67.5%) 
were in WHO clinical stage of  III followed by WHO 
clinical stage IV 23(14.9%) and WHO clinical stage II 
19(12.3%). Only 8(5.2%) study participants who have 
TB/HIV-co infection were found to be in WHO clinical 
stage I.
Chi-square test shows that the TB/HIV co infection is 
significantly associated with marital status, alcohol intake, 
baseline CD4 count, baseline WHO clinical stage, base-
line functional status, TB Smear type (p-value < 0.05) 
(Table 1).
The mean monthly income of  HIV infected partici-
pants was 948.99±800 birr and TB/HIV co-infected 
patients had mean monthly income of  900+707.11 birr. 
The mean age of  HIV mono infected participants was 
33.00+2.83 and TB/HIV co-infected patients had mean 
age of  35.83+8.4 (Table 1).
Multivariate analysis for predicting TB/HIV co-infection
One problem of  single covariate approach is that it ig-
nores the possibility that a collection of  variables, each of  
which is weakly associated with the outcome, can become 
an important predictor of  the outcome when taken to-
gether. It is therefore important to reduce the possibility 
of  excluding variables at the univariable analysis stage.  It 
is for this reason that a univariate test p-value of  0.25 or 
less was used for selection of  variables for the multi co-
variate analysis from single covariate findings. Based on 
this marital status, alcohol intake, smoking status, baseline 
CD4 count, baseline functional status, home ownership 
and baseline WHO stage were selected with forward like-
lihood logistic regression method.
After adjusting other covariates, a patient whose marital 
status was single was 2.17 times more likely to develop 
TB than those patients whose marital status was divorced 
and widowed (Adjusted OR=2.17, 95% CI=1.19-3.96). 
A non smoker was about 69% less likely to develop TB 
than those who were smokers (Adjusted OR=0.31, 95% 
CI= 0.10-0.96).
Low CD4 T-lymphocytes count was the strongest clini-
cal predictor of  TB/HIV co-infection. Patients with CD4 
T-lymphocytes count less than 200 cells/μl were 1.71 
times more likely to develop TB as compared to patients 
with CD4 T-lymphocytes count of  more than 200 cells/
μl (Adjusted OR=1.71, 95%CI=1.09-2.68). Patients in 
WHO clinical stage I were 78% less likely to develop TB 
than that of  the patient in WHO clinical stage IV (Ad-
justed OR=0.22, 95%CI=0.08-0.58). Similarly, patients in 
WHO clinical stage II were about 70% less likely to devel-
op TB than those patient in WHO clinical stage IV (Ad-
justed OR=0.30, 95%CI=0.14-0.66). Patients with am-
bulatory baseline functional status (Adjusted OR=1.73, 
95%CI=1.10-2.78) had an increased risk to develop TB. 
A patient who had a home was about 41% less likely to 
develop TB as compared to those patients who did not 
have their own home (Adjusted OR=0.59, 95%CI=0.39-
0.92). Furthermore, patients who drunk alcohol were 2.26 
times more likely to develop TB than those who did not 
drink (adjusted OR=2.26, 95%CI=1.29-4.02) (Table 2).
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*The relationship is a significant at α=0.05 
Variables TB/HIV Co infection Chi-square p-value 
No,   n(%) Yes,  n(%) 
Sex       
Male  112(27.8) 48(31) 0.457 
Female 291(72.2) 107(69) 
Age       
Mean±SD 33.00+2.83 35.83+8.4 0.894 
Monthly Income       
Mean±SD 948.99±800 900+707.11 0.058 
Educational Status       
No Education 106(26.2) 39(24.8) 
0.961 
Primary 168(41.6) 64(40.8) 
Secondary 81(20) 33(21) 
Certificate and above 49(12.1) 21(13.4) 
Marital Status       
Single 48(11.8) 34(21.7) 
0.017* 
Married 204(50.1) 67(42.7) 
Divorced/separated  90(22) 37(23.6) 
Widowed 65(16) 19(12.1) 
Employment status       
Employed 209(51.9) 70(44.9) 
0.295 Unemployed 94(23.3) 39(25) 
Retired 100(24.8) 47(30.1) 
Residence       
Urban 350(86.8) 130(82.8) 
0.219 Rural 53(13.2) 27(17.2) 
Smoking Status       
Smoker  19(4.7) 5(3.2) 
0.758 Non smoker  388(95.3) 149(96.8) 
Alcohol Intake       
Yes 49(12.3) 31(20.1) 
0.005* No 351(87.8) 123(79.9) 
Baseline CD4 count       
≤200 254(61.5) 121(76.6) 
0.001* >200 159(38.5) 37(23.4) 
Baseline WHO stage       
Stage I 53(13.1) 8(5.2) 
0.000* 
Stage II 94(23.2) 19(12.3) 
Stage III 226(55.7) 104(67.5) 
Stage IV 33(8.1) 23(14.9) 
Missed to take HIV medication     
Yes 3(18.8) 6(3.9) 
0.012* No 13(81.2) 147(96.1) 
Baseline functional status       
Bed driven 25(6.3) 16(10.5) 
0.009* Ambulatory 85(21.4) 47(30.7) 
Working 287(72.3) 90(58.8) 
TB Smear type       
Positive 5(9.3) 21(44.7) 
0.000* 
Negative 48(88.9) 25(53.2) 
Table 1 Summary result of TB/HIV co-infection vs. socio-demographic, economic and clinical,  
and risk variables in Amhara Region, Ethiopia. 
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Table 2 Multi-Covariate and Bivariate Analysis result for different socio-economic, 
demographic, clinical and risk variables that affect TB/HIV Co-infection, Amahra region, 
Ethiopia. 
 
Keys: COR (Crude odds ratio) 
AOR (Adjusted Odds Ratio) 
CI (Confidence Interval) 
1 (Reference Category) 
*Odds Ratio is a significant at α=0.05 
Variables COR(95%CI) COR         P-
value 
AOR(95% CI) AOR         P-
value 
Marital Status         
Single 1.96(1.15-3.35) 0.014* 2.17(1.19-3.96) 0.012* 
Married 0.91(0.60-1.37) 0.650 1.01(0.64-1.59) 0.971 
Divorce and others 1   1   
Smoking status         
Non smoker  0.69(0.25-1.87) 0.247 0.31(0.10-0.96) 0.042* 
Smoker 1   1   
Alcohol Intake         
Yes 1.81(1.10-2.96) 0.005* 2.26(1.29-4.02) 0.005* 
No 1   1   
Baseline CD4 Count         
≤200 cells/μl 2.05(1.35-3.11) 0.001* 1.71(1.09-2.68) 0.019* 
>200 cells/μl 1   1   
Baseline WHO Stage         
Stage I 0.22(0.09-0.54) 0.002* 0.22(0.08-0.58) 0.002* 
Stage II 0.29(0.14-0.59) 0.001* 0.30(0.14-0.66) 0.003* 
Stage III 0.66(0.37-1.18) 0.108 0.63(0.33-1.18) 0.147 
Stage IV 1   1   
Baseline Functional Status         
Bed driven 2.04(1.04-3.99) 0.037* 1.69(0.83-3.49) 0.150 
Ambulatory 1.76(1.15-2.71) 0.009* 1.73(1.10-2.78) 0.020* 
Working 1   1   
Home Ownership         
Yes 0.60(0.41-0.89) 0.012* 0.59(0.39-0.92) 0.018* 
No 1   1   
Residence         
Urban 0.73(0.44-1.21) 0.220     
Rural 1       
Missed to take HIV Medication         
Yes 0.18(0.04-0.79) 0.023*     
No 1       
Discussion
The prevalence of  TB/HIV co-infection in adults on ART 
in our study was moderately high at 27.7%. This is in line 
with other studies12-15. It was slightly lower than 32.8% re-
ported from Nigeria16 and 33% reported from Ethiopia17. 
However, the findings of  this study were higher com-
pared to studies conducted in Ethiopia (7.5%), Nigeria 
(7.8%) and Tanzania (8.5%)2,19-20. These wide variations 
in the co-infection rates of  TB/HIV across the globe, 
as reported, can partly be accounted for by the follow-
ing reasons: coverage level of  highly active antiretroviral 
treatment (HAART), under-reporting, diagnostic proce-
dures used, difference in TB diagnosis, epidemiology of  
TB in different countries and study methodology applied.
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Our study also revealed the determinants of  TB/HIV 
co-infection among HIV-positive adults attending clinical 
care in Amhara region, Ethiopia. Baseline functional sta-
tus, CD4 count, WHO clinical stage, alcohol use, smok-
ing status and home ownership status were independent 
predictors of  TB/HIV co-infection among HIV-positive 
adults.
As CD4+ lymphocyte count decreased the body defence 
mechanism will be overwhelmed by various opportunistic 
infections. The results showed that, patients with CD4 
T- lymphocytes count less than 200 cells/μl  were about 
2 times more likely to develop TB as compared to CD4 
T-lymphocytes count more than 200 cells/μl. A study 
conducted in Nigeria revealed similar finding where low-
er CD4+ lymphocyte count was observed in co-infected 
patients than mono infected patients21. Substance use 
such as cigarette smoking and alcohol consumption were 
the predictors of  TB/HIV co-infection in HIV positive 
in the current study. A study conducted in West Africa 
revealed similar finding where cigarette smoking and al-
cohol consumption were the risk factors for the devel-
opment of  TB22. In contrast, a study from the Gambia 
found that cigarette smoking and alcohol consumption 
were not associated with TB23.
In our study we found that marital status was significantly 
associated with TB. Divorced or widowed Patients were 
less likely to develop TB compared to unmarried (single), 
which is consistent with other reports in West Africa and 
Ethiopia24. It might be explained as unmarried (single) 
persons are younger than married persons and have a 
different lifestyle, especially males, who often migrate to 
towns in search of  a job where they live alone or with 
friends. Similarly, education was not the predictor of  TB/
HIV co-infection in HIV clinic. This result is consistent 
with Kiberet et al.17 and Wondimeneh et al.20 in Ethio-
pia. In contrast, studies from south west Ethiopia9,25 have 
showed that low level of  education was associated with 
TB. This could be due to the high prevalence of  literates 
in our study population.
The other important finding identified was association 
of   patient’s WHO clinical stage with TB-co infection. 
Those patients in first and second WHO clinical stages 
were about 78% and 70% less likely to develop TB com-
pared with those in WHO clinical stages IV, respectively. 
Congruent findings have been reported from in-country 
and outside of  the country10,26,27. This could be explained 
as once the patients get into late stages, the immunity pro-
tective capacity will be minimal which would make them 
prone to tuberculosis infection. A worth to mention as 
well is that TB is one of  the AIDS defining criteria to 
categorize the patients in to the late WHO clinical staging 
which was also used as a criteria in HIV/AIDS clinics in 
Ethiopia.
Patients who were ambulatory at the initiation of  ART 
were about 2 times more likely to develop TB than those 
who were working at the initiation of  ART. This is con-
sistent with the retrospective cohort study in Ethiopia17-18. 
Furthermore, ownership of  the house by the TB patient’s 
family was a predictor of  TB/HIV co-infection among 
HIV positive. A study conducted in West Africa revealed 
similar finding where ownership of  the house by the TB 
patient’s family was associated with lower risk for devel-
oping TB22.
Conclusion and recommendations
The study identified marital status, functional status, 
WHO clinical staging, baseline CD4 count, smoking sta-
tus, alcohol intake, and home ownership were associated 
with TB/HIV co-infection among adult HIV positives. 
In general, advanced clinical disease, smoking and alcohol 
consumption were found to be the main predictors for 
TB/HIV co-infection. All PLWHIV should be screened 
for TB, but for substance abusers and patients with ad-
vanced disease (WHO clinical stage IV, being ambulatory 
and CD4 count<200cell/μl) intensified screening is high-
ly recommended during treatment follow up.
Since the results of  the study underlined risk factors (al-
cohol use and smoking status) as the predictors of  TB/
HIV co-infection in HIV positive, physicians are ex-
pected to work hard to bring about behavioural changes 
towards substance use. According to the results of  this 
study, the main factors associated with TB/HIV co-in-
fection are clinical variables. So, health workers should be 
cautious when a patient has lower CD4 counts, is ambula-
tory at the initiation of  ART and in WHO clinical stage 
IV. Furthermore, the health office should open TB/HIV 
co-infection units in the Hospitals.
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